• About Us
    • TWi USA
    • USA Team
  • Our Products
  • For Customers
    • Authorized Distributors
    • TWi USA State Licenses
    • Return Goods Policy
    • Customer Service Contacts
  • For Patients
    • Adverse Event Reporting, Product Complaints & Medical Information(FOr USA Only)
  • Contact Us

buPROPion Hydrochloride Extended-Release Tablets (XL)

Cyclobenzaprine Hydrochloride Extended-Release Capsules

Dexlansoprazole Delayed-Release Capsules

Diltiazem Hydrochloride Extended-Release Capsules

Dimethyl Fumarate Delayed-Release Capsules

Donepezil tablets

Fenofibric Acid Delayed-Release Capsules

Guanfacine Hydrochloride Extended-Release Tablets

Hydroquinone Cream

MegestrolAcetate Oral Suspension

Metformin Hydrochloride Extended Release Tablets

Metoprolol Succinate Extended-Release Tablets

Mycophenolic Acid DR Tablets

Nifedipine Extended-Release tablets

Paclitaxel Protein-Bound Particles for Injectable Suspension - (Albumin-Bound)

Propafenone Hydrochloride Extended-Release Capsules, USP

Sevelamer Carbonate Tablets

Terbutaline Sulfate tablets

Testosterone Gel, 1.62% CIII

Home > Products > For the United States

Testosterone Gel, 1.62% CIII

Route
Topical
Dosage form
Gel
Strength
1.62%
Rx/OTC
Rx
Indication
Replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
TE Rating
AB
Reference Listed Drug
Androgel®
ANDA#
209390
Strength Form Product Description Imprint How Supplied NDC Number HDMA
Sheets
PI SDS
1.62% Topical Gel Clear, colorless, gel. N/A 1 bottle (in 1 carton) 24979-078-15

BackTop

©Copyright 2016 TWi Pharmaceuticals USA, Inc. All rights reserved.